Insider · CIK 0001562371
Richard Barry
Files at SRPT (Sarepta Therapeutics, Inc.), FLNA (CASSAVA SCIENCES INC). First filing Sep 22, 2025, latest Oct 1, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
FLNA: CASSAVA SCIENCES INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | FLNAbuy CASSAVA SCIENCES INC | $278k 306,813 shares | +30% | +35% from low-80% from high | |
| 45Moderate | FLNAbuy CASSAVA SCIENCES INC | $78k 93,091 shares | +10% | +25% from low-82% from high | |
| 65Notable | CASSAVA SCIENCES INC | $414k 150,000 shares | +19% | +121% from low-92% from high | |
| 61Notable | CASSAVA SCIENCES INC | $202k 73,385 shares | +10% | +131% from low-91% from high | |
| 46Moderate | CASSAVA SCIENCES INC | $16k 7,172 shares | +1% | +95% from low-93% from high | |
| 69Notable | CASSAVA SCIENCES INC | $535k 237,941 shares | +51% | +92% from low-93% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | FLNA CASSAVA SCIENCES INC | POpen-market purchase Common Stockindirect: By Trust | +206,813 | $0.90 | $186k | 1,237,964 | 11 d ago |
| Sep 30, 2026 | FLNA CASSAVA SCIENCES INC | POpen-market purchase Common Stockindirect: By Trust | +100,000 | $0.92 | $92k | 1,337,964 | 11 d ago |
| Sep 28, 2026 | FLNA CASSAVA SCIENCES INC | POpen-market purchase Common Stockindirect: By Trust | +93,091 | $0.84 | $78k | 1,031,151 | 12 d ago |
| Nov 20, 2025 | FLNA CASSAVA SCIENCES INC | POpen-market purchase Common Stockindirect: By Trust | +150,000 | $2.76 | $414k | 938,060 | Nov 24, 2025 |
| Nov 19, 2025 | FLNA CASSAVA SCIENCES INC | POpen-market purchase Common Stockindirect: By Trust | +73,385 | $2.75 | $202k | 788,060 | Nov 20, 2025 |
| Sep 22, 2025 | FLNA CASSAVA SCIENCES INC | POpen-market purchase Common Stockindirect: By Trust | +7,172 | $2.28 | $16k | 714,675 | Sep 23, 2025 |
| Sep 18, 2025 | FLNA CASSAVA SCIENCES INC | POpen-market purchase Common Stockindirect: By Trust | +5,400 | $2.13 | $12k | 474,962 | Sep 22, 2025 |
| Sep 18, 2025 | FLNA CASSAVA SCIENCES INC | POpen-market purchase Common Stockindirect: By Trust | +185,233 | $2.24 | $415k | 660,195 | Sep 22, 2025 |
| Sep 19, 2025 | FLNA CASSAVA SCIENCES INC | POpen-market purchase Common Stockindirect: By Trust | +400 | $2.25 | $900 | 660,595 | Sep 22, 2025 |
| Sep 19, 2025 | FLNA CASSAVA SCIENCES INC | POpen-market purchase Common Stockindirect: By Trust | +46,908 | $2.29 | $107k | 707,503 | Sep 22, 2025 |
| May 16, 2025 | SRPT Sarepta Therapeutics, Inc. | MOption exercise Common Stock | +12,350 | $32.63 | $403k | 2,966,667 | May 19, 2025 |
| May 16, 2025 | SRPT Sarepta Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative | -12,350 | $0.00 | $0 | 0 | May 19, 2025 |
| May 13, 2025 | SRPT Sarepta Therapeutics, Inc. | MOption exercise Common Stock | +9,746 | $25.18 | $245k | 2,943,817 | May 15, 2025 |
| May 13, 2025 | SRPT Sarepta Therapeutics, Inc. | MOption exercise Common Stock | +10,500 | $13.71 | $144k | 2,954,317 | May 15, 2025 |
| May 13, 2025 | SRPT Sarepta Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative | -9,746 | $0.00 | $0 | 0 | May 15, 2025 |
| May 13, 2025 | SRPT Sarepta Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative | -10,500 | $0.00 | $0 | 0 | May 15, 2025 |
| Apr 17, 2025 | FLNA CASSAVA SCIENCES INC | AGrant or award Stock Option (Right to Buy)derivative | +350,000 | $0.00 | $0 | 350,000 | Apr 21, 2025 |
| Mar 10, 2025 | SRPT Sarepta Therapeutics, Inc. | AGrant or award Common Stock | +2,383 | $0.00 | $0 | 2,934,071 | Mar 11, 2025 |
| Mar 10, 2025 | SRPT Sarepta Therapeutics, Inc. | AGrant or award Stock Options (right to buy)derivative | +4,792 | $0.00 | $0 | 4,792 | Mar 11, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.